{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:42:51Z","timestamp":1758588171145,"version":"3.44.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.transproceed.2020.01.103","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:31:14Z","timestamp":1586824274000},"page":"2440-2446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modified Model for End-Stage Liver Disease Is an Indicator of the Ineffectiveness of Sildenafil Treatment in Patients With Advanced Heart Failure and Increased Pulmonary Vascular Resistance"],"prefix":"10.1016","volume":"52","author":[{"given":"Wioletta","family":"Szczurek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"G\u0105sior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Skrzypek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Kaczmarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u017cena","family":"Szygu\u0142a-Jurkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2020.01.103_bib1","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jacc.2017.01.051","article-title":"Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging clinical perspectives","volume":"69","author":"Guazzi","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.transproceed.2020.01.103_bib2","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.102.14.1718","article-title":"Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management","volume":"102","author":"Moraes","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2020.01.103_bib3","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.hlc.2018.04.299","article-title":"Left ventricular assist devices in pulmonary hypertension group 2 with significantly elevated pulmonary vascular resistance: a bridge to cure","volume":"28","author":"Selim","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.transproceed.2020.01.103_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijcard.2012.09.074","article-title":"The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study","volume":"168","author":"Reichenbach","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.transproceed.2020.01.103_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2020.01.103_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1388-9842(03)00059-X","article-title":"Reversible pulmonary hypertension in heart transplant candidates---pretransplant evaluation and outcome after orthotopic heart transplantation","volume":"5","author":"Klotz","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.transproceed.2020.01.103_bib7","first-page":"69","article-title":"Hemodynamic and clinical benefits associated with chronic sildenafil therapy in advanced heart failure: experience of the Montr\u00e9al Heart Institute","volume":"28","author":"Potter","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.transproceed.2020.01.103_bib8","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/bph.14205","article-title":"PDE5 inhibitors---pharmacology and clinical applications 20 years after sildenafil discovery","volume":"75","author":"Andersson","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.transproceed.2020.01.103_bib9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.107.716373","article-title":"Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension","volume":"116","author":"Lewis","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2020.01.103_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.transproceed.2020.01.103_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.healun.2012.02.008","article-title":"Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction","volume":"31","author":"Chokshi","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2020.01.103_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000487199","article-title":"Pulmonary arterial hypertension and the kidney: getting to the heart of the matter","volume":"47","author":"Kazory","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.transproceed.2020.01.103_bib13","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","article-title":"Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"95","author":"House","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2020.01.103_bib14","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","article-title":"The kidney in heart failure: an update","volume":"36","author":"Damman","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.transproceed.2020.01.103_bib15","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.cardfail.2012.10.010","article-title":"Congestive renal failure: the pathophysiology and treatment of renal venous hypertension","volume":"18","author":"Ross","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.transproceed.2020.01.103_bib16","first-page":"178","article-title":"The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation","volume":"11","author":"Szygu\u0142a-Jurkiewicz","year":"2014","journal-title":"Kardiochir Torakochirurgia Pol"},{"key":"10.1016\/j.transproceed.2020.01.103_bib17","first-page":"244","article-title":"Liver complications in patients with congestive heart failure","volume":"9","author":"Giallourakis","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"8 Suppl","key":"10.1016\/j.transproceed.2020.01.103_bib18","first-page":"7S","article-title":"Diabetes mellitus and hypertension: key risk factors for kidney disease","volume":"94","author":"Lea","year":"2002","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.transproceed.2020.01.103_bib19","doi-asserted-by":"crossref","first-page":"9127847","DOI":"10.1155\/2017\/9127847","article-title":"Associations of fatty liver disease with hypertension, diabetes, and dyslipidemia: comparison between alcoholic and nonalcoholic steatohepatitis","volume":"2017","author":"Toshikuni","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.transproceed.2020.01.103_bib20","first-page":"235","article-title":"Prognostic utility of the N terminal prohormone of brain natriuretic peptide and the modified Model for End Stage Liver Disease in patients with end stage heart failure","volume":"128","author":"Szczurek","year":"2018","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.transproceed.2020.01.103_bib21","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.healun.2019.08.007","article-title":"Usefulness of combining prognostic scores to predict survival in patients with advanced heart failure","volume":"38","author":"Szczurek","year":"2019","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2020.01.103_bib22","first-page":"254","article-title":"One-year survival of ambulatory patients with end-stage heart failure: the analysis of prognostic factors","volume":"127","author":"Szygula-Jurkiewicz","year":"2017","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.transproceed.2020.01.103_bib23","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.transproceed.2007.08.069","article-title":"Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates","volume":"39","author":"Zakliczynski","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2020.01.103_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/685548","article-title":"Sildenafil in heart failure with reactive pulmonary hypertension (Sildenafil HF) clinical trial (rationale and design)","volume":"6","author":"Guglin","year":"2016","journal-title":"Pulm Circ"},{"key":"10.1016\/j.transproceed.2020.01.103_bib25","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ejheart.2007.01.008","article-title":"Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation","volume":"9","author":"Jabbour","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.transproceed.2020.01.103_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCHEARTFAILURE.110.957050","article-title":"Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure","volume":"4","author":"Yin","year":"2011","journal-title":"Circ Heart Fail"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519317208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519317208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:36:56Z","timestamp":1758577016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519317208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0041134519317208"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.103","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modified Model for End-Stage Liver Disease Is an Indicator of the Ineffectiveness of Sildenafil Treatment in Patients With Advanced Heart Failure and Increased Pulmonary Vascular Resistance","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}